pharmaphorum

JULY 4, 2022

At Teva , he replaces Hafrun Fridriksdottir, a 25-year Teva veteran who was named R&D chief almost immediately after Kare Schultz took over the reins of Teva in 2017 with the task of turning around the fortunes of the ailing generics giant. ” The post Teva poaches Vertex exec as new head of R&D appeared first on.

Medicine 52

Medicine Specialization Competition Medical 52

European Pharmaceutical Review

JUNE 24, 2022

This suggests that any of the modelled changes to the regulation could lead to a decrease in the number of OMPs developed… Some of the assessed changes to the regulation could undermine the business model under which OMP?focused Maarten has significant competition law experience in a variety of sectors. About the author. References.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Contrarian Sales Techniques

DECEMBER 22, 2020

The lead includes more than 1,000 biotech start-ups created between 2012 and 2016, with a further 500 founded in 2017. According to the World Economic Forum's 2017 Global Competitiveness Report, the Association of Southeast Asian Nations (ASEAN) is on track to become Asia's next economic powerhouse.

Government 52

Government Competition Pharmaceutical Management 52

pharmaphorum

JULY 15, 2022

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

Prescription 52

Prescription Marketing Doctors Government 52

European Pharmaceutical Review

DECEMBER 22, 2022

In recent years significant improvements in automation of cell line development have reduced timelines for demonstrating productivity and clonality of lead cell lines from months to weeks. Using this data, it was possible to select a lead cell line that was scalable and produced 8 g/l across 15ml to 200l (see Figure 2 ).

Manufacturing 98

Manufacturing Leads Engineering Pharmaceutical 98

European Pharmaceutical Review

JULY 4, 2024

20 Good manufacturing practice (GMP) Commission Directive (EU) 2017/1572 (which supplemented Directive 2001/83/EC) lays out the principles and guidelines of GMP in the EU. Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets.

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

CloserIQ

OCTOBER 10, 2018

ProfitWell is an emerging company, having completed a $10 million Series A funding round in 2017. They’ve worked with leading clients such as Twitter and Mercedes Benz. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2017. Founded 2017. $9

Sales 76

Sales Management Marketing Education 76

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Pharmaceutical Technology

NOVEMBER 30, 2022

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% The same can be said for the US.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% The same can be said for the US.

Medical 98

Medical Manufacturing Insurance Side effects 98

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Evolve Your Success

AUGUST 8, 2023

I’ve been in medical device for years starting in 2017. The medical device is super competitive. I got to say, for being in the game since 2017, you sound like you’ve mastered a lot in what you’re doing. No complaints. Why don’t you tell us who you are and what you do? My name is Alex Matthews. Love the show?

Sales 130

Sales Medical Management Patients 130

Pharmaceutical Technology

JUNE 22, 2023

The voucher approach was already debated in the months leading up to the announcement. The EU previously focused on AMR through the One Health Action Plan, which was released in 2017. Hence, some experts remain unsure of how the scheme will incentivise the development of new drugs to fight AMR.

Pharma 52

Pharma Pharmaceutical Government Marketing 52

Spotio

JUNE 6, 2022

Sales Prospecting Statistics The way companies prospect for leads is changing. HubSpot] 9 in 10 companies use 2+ lead enrichment tools to learn more about prospects. Invest in a toolset that allows you to quickly build profiles and find accurate lead data in your target market. With so much potential, comes a lot of competition.

Sales 111

Sales Prospecting B2B Sales Leads 111

Impetus Digital

MARCH 15, 2024

Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). Specific challenges facing the oncology field 1.

Recruitment 78

Recruitment Patients Healthcare Provider Healthcare 78

pharmaphorum

JUNE 28, 2022

Broader use could bring lenacapavir into competition with ViiV’s long-acting injectable Cabenuva (cabotegravir/rilpivirine), partnered with Johnson & Johnson, which is delivered monthly as an alternative to daily ART. Both therapies are already used for this use in the US.

FDA 105

FDA Marketing Medicine Sales 105

pharmaphorum

JULY 12, 2022

The deal centres on La Jolla’s lead product Giapreza (angiotensin II), used to increase blood pressure in adults with septic shock, and antibiotic Xerava (eravacycline) for complicated intra-abdominal infections (cIAIs), approved by the FDA in 2017 and 2018, respectively.

Pharma 52

Pharma Sales Marketing Competition 52

pharmaphorum

NOVEMBER 15, 2022

Indivior says the experimental drug has been specifically designed to tackle the surge in highly potent, synthetic opioids like fentanyl, which have swept through the US in recent years leading to a surge in overdoses and deaths.

Sales 52

Sales Marketing FDA Pharma 52

pharmaphorum

AUGUST 5, 2022

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. For instance, these players were responsible for approximately 55% of all drugs brought to market between 2017 and 2021— nearly double that for the preceding five-year period (at 30%). About the Author.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

Clarivate

OCTOBER 17, 2024

As California Attorney General from 2011 to 2017, Harris was a forceful opponent of healthcare industry consolidation, both vertical and horizontal, believing that mergers of hospitals, physician groups and insurers would damage competition and raise prices for care.

Healthcare 52

Healthcare Healthcare Government Insurance 52